Efficacy and Safety of Bortezomib as add-on Treatment in Relapsing Neuromyelitis Optica Spectrum Disorder
Clinical trial NCT02893111 · COMPLETED
Trial details
- NCT number
- NCT02893111
- Sponsor
- Tianjin Medical University General Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2016-12-25
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.